170 related articles for article (PubMed ID: 24257269)
1. Impact of MLC leaf width on volumetric-modulated arc therapy planning for head and neck cancers.
Lafond C; Chajon E; Devillers A; Louvel G; Toublanc S; Olivier M; Simon A; De Crevoisier R; Manens JP
J Appl Clin Med Phys; 2013 Nov; 14(6):4074. PubMed ID: 24257269
[TBL] [Abstract][Full Text] [Related]
2. Dosimetric effects of multileaf collimator leaf width on intensity-modulated radiotherapy for head and neck cancer.
Hong CS; Ju SG; Kim M; Kim JI; Kim JM; Suh TS; Han Y; Ahn YC; Choi DH; Nam H; Park HC
Med Phys; 2014 Feb; 41(2):021712. PubMed ID: 24506603
[TBL] [Abstract][Full Text] [Related]
3. Treatment planning strategy for whole-brain radiotherapy with hippocampal sparing and simultaneous integrated boost for multiple brain metastases using intensity-modulated arc therapy.
Pokhrel D; Sood S; McClinton C; Shen X; Lominska C; Saleh H; Badkul R; Jiang H; Mitchell M; Wang F
Med Dosim; 2016 Winter; 41(4):315-322. PubMed ID: 27692518
[TBL] [Abstract][Full Text] [Related]
4. New possibilities for volumetric-modulated arc therapy using the Agility™ 160-leaf multileaf collimator.
Blümer N; Scherf C; Köhn J; Kara E; Loutfi-Krauß B; Imhoff D; Rödel C; Ramm U; Licher J
Strahlenther Onkol; 2014 Oct; 190(11):1066-74. PubMed ID: 25060175
[TBL] [Abstract][Full Text] [Related]
5. Is there a dosimetric advantage of volumetric modulated arc therapy over intensity modulated radiotherapy in head and neck cancer?
Buciuman N; Marcu LG
Eur Arch Otorhinolaryngol; 2022 Nov; 279(11):5311-5321. PubMed ID: 35598230
[TBL] [Abstract][Full Text] [Related]
6. Optimal VMAT Delivery for Elekta MLC Beam Modulator: A Study of Collimator Rotation for Head and Neck Planning.
Murtaza G; Mehmood S; Silvia Favretto M; Cora S
J Med Imaging Radiat Sci; 2020 Jun; 51(2):289-298. PubMed ID: 32229103
[TBL] [Abstract][Full Text] [Related]
7. A dosimetric comparison of the use of equally spaced beam (ESB), beam angle optimization (BAO), and volumetric modulated arc therapy (VMAT) in head and neck cancers treated by intensity modulated radiotherapy.
Leung WS; Wu VWC; Liu CYW; Cheng ACK
J Appl Clin Med Phys; 2019 Nov; 20(11):121-130. PubMed ID: 31593367
[TBL] [Abstract][Full Text] [Related]
8. Analysis of direct clinical consequences of MLC positional errors in volumetric-modulated arc therapy using 3D dosimetry system.
Nithiyanantham K; Mani GK; Subramani V; Mueller L; Palaniappan KK; Kataria T
J Appl Clin Med Phys; 2015 Sep; 16(5):296–305. PubMed ID: 26699311
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric evaluation study of IMRT and VMAT techniques for prostate cancer based on different multileaf collimator designs.
Fathy MM; Hassan BZ; El-Gebaly RH; Mokhtar MH
Radiat Environ Biophys; 2023 Mar; 62(1):97-106. PubMed ID: 36576578
[TBL] [Abstract][Full Text] [Related]
10. Assessing the feasibility of volumetric-modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high-risk prostate and rectal cancer cases.
Cilla S; Deodato F; Digesù C; Macchia G; Picardi V; Ferro M; Sallustio G; De Spirito M; Piermattei A; Morganti AG
Med Dosim; 2014; 39(1):108-16. PubMed ID: 24342167
[TBL] [Abstract][Full Text] [Related]
11. Volumetric-modulated arc therapy for the treatment of a large planning target volume in thoracic esophageal cancer.
Abbas AS; Moseley D; Kassam Z; Kim SM; Cho C
J Appl Clin Med Phys; 2013 May; 14(3):4269. PubMed ID: 23652258
[TBL] [Abstract][Full Text] [Related]
12. A radiobiological and dosimetrical comparison between simultaneous integrated and sequential boost intensity-modulated arc treatment of locally advanced head-and-neck cancer.
Mandal A; Choudhary S; Mani N; Aggarwal SK
J Cancer Res Ther; 2020; 16(3):508-512. PubMed ID: 32719258
[TBL] [Abstract][Full Text] [Related]
13. Volumetric modulated arc therapy treatment planning of thoracic vertebral metastases using stereotactic body radiotherapy.
Mallory M; Pokhrel D; Badkul R; Jiang H; Lominska C; Wang F
J Appl Clin Med Phys; 2018 Mar; 19(2):54-61. PubMed ID: 29349867
[TBL] [Abstract][Full Text] [Related]
14. Volumetric-modulated arc therapy vs. c-IMRT in esophageal cancer: a treatment planning comparison.
Yin L; Wu H; Gong J; Geng JH; Jiang F; Shi AH; Yu R; Li YH; Han SK; Xu B; Zhu GY
World J Gastroenterol; 2012 Oct; 18(37):5266-75. PubMed ID: 23066322
[TBL] [Abstract][Full Text] [Related]
15. Impact of MLC properties and IMRT technique in meningioma and head-and-neck treatments.
Kantz S; Söhn M; Troeller A; Reiner M; Weingandt H; Alber M; Belka C; Ganswindt U
Radiat Oncol; 2015 Sep; 10():184. PubMed ID: 26328628
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric comparison of VMAT standard optimization (SO) and multi-criteria optimization (MCO) treatment plans with standard mode delivery (STD) or sliding window (SW) for head and neck cancer.
Rolland J; Favrel V; Fau P; Mailleux H; Tallet A
J Appl Clin Med Phys; 2023 Sep; 24(9):e14013. PubMed ID: 37144958
[TBL] [Abstract][Full Text] [Related]
17. Influence of multi-leaf collimator leaf transmission on head and neck intensity-modulated radiation therapy and volumetric-modulated arc therapy planning.
Sasaki M; Tominaga M; Kamomae T; Ikushima H; Kitaoka M; Bando R; Sakuragawa K; Oita M
Jpn J Radiol; 2017 Sep; 35(9):511-525. PubMed ID: 28647834
[TBL] [Abstract][Full Text] [Related]
18. ART for head and neck patients: On the difference between VMAT and IMPT.
Góra J; Kuess P; Stock M; Andrzejewski P; Knäusl B; Paskeviciute B; Altorjai G; Georg D
Acta Oncol; 2015; 54(8):1166-74. PubMed ID: 25850583
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric comparison of head and neck cancer patients planned with multivendor volumetric modulated arc therapy technology.
Kathirvel M; Subramani V; Subramanian VS; Swamy ST; Arun G; Kala S
J Cancer Res Ther; 2017; 13(1):122-130. PubMed ID: 28508845
[TBL] [Abstract][Full Text] [Related]
20. Dose-escalated volumetric modulated arc therapy for total marrow irradiation: A feasibility dosimetric study with 4DCT planning and simultaneous integrated boost.
Jaccard M; Lamanna G; Kountouri M; Rouzaud M; Miralbell R; Zilli T
Phys Med; 2020 Oct; 78():123-128. PubMed ID: 33002733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
